Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

被引:1099
作者
Guidotti, LG
Ishikawa, T
Hobbs, MV
Matzke, B
Schreiber, R
Chisari, FV
机构
[1] SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA
[2] UNIV PARMA, IST PATOL GEN, I-43100 PARMA, ITALY
[3] WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA
关键词
D O I
10.1016/S1074-7613(00)80295-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
It is widely believed that viral clearance is mediated principally by the destruction of infected cells by CTLs. In this report, we use a transgenic mouse model of HBV replication to demonstrate that this assumption may not be true for all viruses. We find that adoptively transferred virus-specific CTLs can abolish HBV gene expression and replication in the liver without killing the hepatocytes. This antiviral function is mediated by IFN gamma and TNF alpha secreted by the CTL or by the antigen-nonspecific macrophages and T cells that they activate following antigen recognition. These cytokines activate two independent virocidal pathways: the first pathway eliminates HBV nucleocapsid particles and their cargo of replicating viral genomes, while the second pathway destabilizes the viral RNA. Intracellular viral inactivation mechanisms such as these could greatly amplify the protective effects of the immune response, while failure of such mechanisms could lead to viral persistence or to the death of the host.
引用
收藏
页码:25 / 36
页数:12
相关论文
共 36 条
[1]
MECHANISMS OF CLASS-I RESTRICTED IMMUNOPATHOLOGY - A TRANSGENIC MOUSE MODEL OF FULMINANT-HEPATITIS [J].
ANDO, K ;
MORIYAMA, T ;
GUIDOTTI, LG ;
WIRTH, S ;
SCHREIBER, RD ;
SCHLICHT, HJ ;
HUANG, SN ;
CHISARI, FV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1541-1554
[2]
ANDO K, 1994, J IMMUNOL, V152, P3245
[3]
BIOLOGY OF CLONED CYTO-TOXIC LYMPHOCYTES-T SPECIFIC FOR LYMPHOCYTIC CHORIOMENINGITIS VIRUS - CLEARANCE OF VIRUS INVIVO [J].
BYRNE, JA ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1984, 51 (03) :682-686
[4]
MOLECULAR PATHOGENESIS OF HEPATOCELLULAR-CARCINOMA IN HEPATITIS-B VIRUS TRANSGENIC MICE [J].
CHISARI, FV ;
KLOPCHIN, K ;
MORIYAMA, T ;
PASQUINELLI, C ;
DUNSFORD, HA ;
SELL, S ;
PINKERT, CA ;
BRINSTER, RL ;
PALMITER, RD .
CELL, 1989, 59 (06) :1145-1156
[5]
CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333
[6]
EXPRESSION OF HEPATITIS-B VIRUS LARGE ENVELOPE POLYPEPTIDE INHIBITS HEPATITIS-B SURFACE-ANTIGEN SECRETION IN TRANSGENIC MICE [J].
CHISARI, FV ;
FILIPPI, P ;
MCLACHLAN, A ;
MILICH, DR ;
RIGGS, M ;
LEE, S ;
PALMITER, RD ;
PINKERT, CA ;
BRINSTER, RL .
JOURNAL OF VIROLOGY, 1986, 60 (03) :880-887
[7]
SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[8]
EVIDENCE THAT HEPATOCYTE TURNOVER IS REQUIRED FOR RAPID CLEARANCE OF DUCK HEPATITIS-B VIRUS DURING ANTIVIRAL THERAPY OF CHRONICALLY INFECTED DUCKS [J].
FOUREL, I ;
CULLEN, JM ;
SAPUTELLI, J ;
ALDRICH, CE ;
SCHAFFER, P ;
AVERETT, DR ;
PUGH, J ;
MASON, WS .
JOURNAL OF VIROLOGY, 1994, 68 (12) :8321-8330
[9]
THE MOLECULAR-BIOLOGY OF THE HEPATITIS-B VIRUSES [J].
GANEM, D ;
VARMUS, HE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :651-693
[10]
Gegin Cem, 1992, Journal of Immunology, V149, P3331